InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Lyell Immunopharma, Inc.

LYEL Clue Score29
United States Fiscal year ends December CIK 0001806952 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
ARCH Venture Fund XIII, L.P.
4 Nov 2026
10% owner
Buy indirect
2,321,262
$10.77
$25.00M
ARCH Venture Partners IX, LLC
4 Nov 2026
10% owner
Buy indirect
2,321,262
$10.77
$25.00M
Jarrad Mattieu Aguirre
12 Oct 2026
Chief Medical Officer
Sell
422
$8.63
$3.64K
David Shook
10 Sep 2026
Chief Medical Officer
Sell
500
$12.70
$6.35K
Gary K. Lee
21 Aug 2026
Chief Scientific Officer
Sell
1,457
$15.54
$22.64K
Stephen J. Hill
21 Aug 2026
Chief Operating Officer
Sell
989
$15.54
$15.37K
Lynn Seely
21 Aug 2026
President and CEO
Sell
9,589
$15.54
$149.01K
Lynn Seely
10 Aug 2026
President and CEO
Sell
390
$14.34
$5.59K
Stephen J. Hill
10 Aug 2026
Chief Operating Officer
Sell
89
$14.34
$1.28K
Gary K. Lee
10 Aug 2026
Chief Scientific Officer
Sell
131
$14.34
$1.88K
Veronica Sanchez Bulis
10 Aug 2026
VP, Corporate Controller
Sell
621
$14.34
$8.91K
Innovative Cellular Therapeutics Holdings Ltd
17 Jul 2026
10% owner
Sold on a plan
10
$13.70
$137.00
Innovative Cellular Therapeutics Holdings Ltd
16 Jul 2026
10% owner
Sold on a plan
10
$13.73
$137.30
David Shook
10 Jun 2026
Chief Medical Officer
Sell
1,977
$12.64
$24.99K
Veronica Sanchez Bulis
11 May 2026
VP, Corporate Controller
Sell
217
$18.91
$4.10K
Stephen J. Hill
11 May 2026
Chief Operating Officer
Sell
89
$18.92
$1.68K
Gary K. Lee
11 May 2026
Chief Scientific Officer
Sell
130
$18.92
$2.46K
Lynn Seely
11 May 2026
President and CEO
Sell
388
$18.91
$7.34K
ARCH Venture Fund XIII, L.P.
6 Mar 2026
10% owner
Buy indirect
488,090
$25.61
$12.50M
ARCH Venture Partners IX, LLC
6 Mar 2026
10% owner
Buy indirect
488,090
$25.61
$12.50M
Gary K. Lee
11 Feb 2026
Chief Scientific Officer
Sell
1,671
$23.39
$39.08K
Stephen J. Hill
11 Feb 2026
Chief Operating Officer
Sell
1,236
$23.39
$28.91K
Lynn Seely
11 Feb 2026
President and CEO
Sell
7,455
$23.39
$174.37K
Veronica Sanchez Bulis
10 Feb 2026
VP, Corporate Controller
Sell
254
$23.12
$5.87K
Lynn Seely
10 Feb 2026
President and CEO
Sell
438
$23.12
$10.13K
Gary K. Lee
10 Feb 2026
Chief Scientific Officer
Sell
147
$23.12
$3.40K
Stephen J. Hill
10 Feb 2026
Chief Operating Officer
Sell
109
$23.12
$2.52K
Veronica Sanchez Bulis
30 Dec 2025
VP, Corporate Controller
Sell
936
$32.32
$30.25K
Veronica Sanchez Bulis
24 Dec 2025
VP, Corporate Controller
Sell
1,136
$38.67
$43.93K
Stephen J. Hill
10 Nov 2025
Chief Operating Officer
Sell
95
$16.12
$1.53K
Gary K. Lee
10 Nov 2025
Chief Scientific Officer
Sell
138
$16.16
$2.23K
Veronica Sanchez Bulis
10 Nov 2025
VP, Corporate Controller
Sell
239
$16.10
$3.85K
Lynn Seely
10 Nov 2025
President and CEO
Sell
412
$16.11
$6.64K

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 27
Transactions with no price 0
Shares from compensation/vesting 261,750
History held since 23 Jun 2021